Status:
TERMINATED
Use of Maytenus Ilicifolia in the Treatment of Dyspepsia
Lead Sponsor:
Casa Espirita Terra de Ismael
Collaborating Sponsors:
University of Sao Paulo
Conditions:
Dyspepsia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary...
Eligibility Criteria
Inclusion
- age \> 18 years
- being literate
- diagnosis of dyspepsia
- initial SODA score \> or = 25
Exclusion
- pregnancy
- lactation
- allergy to Maytenus species
- fail to use the drug for 3 uninterrupted weeks
- new onset serious adverse events, attributable to the drug
- patient's request
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01408849
Start Date
February 1 2015
End Date
January 1 2016
Last Update
July 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clinicas FMRP-USP
Ribeirão Preto, São Paulo, Brazil, 14049-900